Search

Avita announces major trial changes

Perth biotechnology firm Avita Medical has announced major changes to a clinical trial in the US it hopes will improve shareholder confidence.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
421stPura Vida Energy6%-40%
542ndAdvanced Braking Technology-14%-20%
638thSuda Pharmaceuticals-30%-16%
662ndResource Development Group-34%-32%
750thAvita Medical-51%-13%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

88th↑Pura Vida Energy$9.4m
89th↓Resource Development Group$9.3m
90th↑Avita Medical$8.0m
91st↓Advanced Braking Technology$7.7m
92nd↓Suda Pharmaceuticals$7.3m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

237thTim Rooney$506k
354thAndrew Quick$366k
637thLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer